{"nctId":"NCT00411554","briefTitle":"A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)","startDateStruct":{"date":"2007-01"},"conditions":["Diabetes Mellitus, Non-Insulin-Dependent"],"count":319,"armGroups":[{"label":"Sitagliptin 50 mg QD","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin phosphate"]},{"label":"Voglibose 0.2 mg TID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: voglibose"]}],"interventions":[{"name":"sitagliptin phosphate","otherNames":["MK0431"]},{"name":"Comparator: voglibose","otherNames":["voglibose"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients have type 2 diabetes mellitus on diet/exercise therapy\n\nExclusion Criteria:\n\n* Patients have type 1 diabetes mellitus","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in HbA1c at Week 12","description":"HbA1c is measured as a percent. Thus, this change from baseline reflects the Week 12 HbA1c percent minus the Week 0 HbA1c percent.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.70","spread":null},{"groupId":"OG001","value":"-0.30","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose at Week 12","description":"Change from baseline at Week 12 is defined as fasting plasma glucose at Week 12 minus fasting plasma glucose at Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.6","spread":null},{"groupId":"OG001","value":"-8.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in 2 Hour Postprandial Glucose at Week 12","description":"Change from baseline at Week 12 is defined as 2-hour postprandial glucose Week 12 minus 2-hour postprandial glucose Week 0.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.0","spread":null},{"groupId":"OG001","value":"-32.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Nasopharyngitis","Flatulence","Abdominal distension","Diarrhoea","Alanine aminotransferase increased"]}}}